Relationship between serum levels of osteocalcin and atherosclerotic disease in type 2 diabetes

Diabetes and Metabolism

Volumn 38, Issue 1, 2012, Pages 76-81

  Reyes Garcia, R ^a   Rozas Moreno, P ^a,b   Jimenez Moleon, J J ^c   Villoslada, M J Lara ^a   Garcia Salcedo, J A ^a   Santana Morales, S ^a   Munoz Torres M ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE CIUDAD REAL   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

Author keywords

Atherosclerosis; Osteocalcin; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C; OSTEOCALCIN;

ADULT; AGED; AORTA OCCLUSION; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RADIOIMMUNOASSAY;

ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CALCINOSIS; CAROTID ARTERIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; OSTEOCALCIN; TUNICA INTIMA;

EID: 84856736037     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2011.07.008     Document Type: Article

References (21)

1. Vogt M.T., San Valentin R., Forrest K.Y., Mevvit M.C., Cauley J.A. Bone mineral density and aortic calcification: the study of osteoporotic fractures. J Am Geriatr Soc 1997, 45:140-145.
2. Reck P., Hansen M.A., Hassager C. The association between low bone mass at the menopause and cardiovascular mortality. Am J Med 1999, 106:273-278.
3. McFarlane S.I., Muniyappa R., Shin J.J., Bathiyar G., Sowers J.R. Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link?. Endocrine 2004, 23:1-10.
4. Tanko L.B., Christiansen C., Cox D.A., Geiger M.J., McNabb M.A., Cummings S.R. Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res 2005, 20:1912-1920.
5. Sambrook P.N., Chen C.J.S., March L.M., Cameron I.D., Cumming R.G., Lord S.R., et al. High bone turnover is an independent predictor of mortality in the frail elderly. J Bone Miner Res 2006, 21:549-555.
6. Gadeau A.P., Chaulet H., Daret D., Kockx M., Daniel-Lamaziere J.M., Desgranges C. Time course of osteopontin, osteocalcin and osteonectin accumulation and calcification after acute vessel wall injury. J Histochem Cytochem 2001, 49:79-86.
7. Dhore C.R., Cleutjens J.P., Lutgens E., Clutjens K.G., Geusens P.P., Kitslaar P.J., et al. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2001, 1988-2003.
8. Montalcini T., Emanuele V., Ceravolo R., Gorgone G., Sesti G., Perticone F., et al. Relation of low bone mineral density and carotid atherosclerosis in postmenopausal women. Am J Cardiol 2004, 94:266-269.
9. Gosll M., Modder U.I., Atkinson E.J., Lerman A., Khosla S. Osteocalcin expression by circulating endothelial progenitor cells in patients with coronary atheroesclerosis. J Am Coll Cardiol 2008, 52:1314-1325.
10. Kanazawa I., Yamaguchi T., Yamamoto M., Yamauchi M., Kurioka S., Yano S., et al. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab 2009, 94:45-49.
11. Pennisi P., Signorelli S.S., Riccobene S., Celotta G., Di Pino L., La Malfa T., et al. Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. Osteoporos Int 2004, 15:389-395.
12. Braam L.A., Dossel P., Gijsbers B.L., Spronk H.M., Hmaulyak K., Soute B.A., et al. Assay for human matrix Gla protein in serum: potential applications in cardiovascular field. Arterioscler Thromb Vasc Biol 2000, 20:1257-1261.
13. Lee L.A., Sowa H., Hinoi E., Ferron M., Ahn D.J., Confavreux C., et al. Endocrine regulation of energy metabolism by skeleton. Cell 2007, 130:456-469.
14. Ferron M., Hinoi E., Karsenty G., Ducy P. Osteocalcin differentially regulates ß cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA 2008, 105:5266-5270.
15. Kindblom J.M., Ohlsson C., Ljunggren O., Karlsson M.K., Tivesten A., Smith U., et al. Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men. J Bone Miner Res 2009, 24:785-791.
16. Foresta C., Strapazzon G., De Toni L., Gianesello L., Calcagno A., Pilon C., et al. Evidence for osteocalcin production by adipose tissue and its role in human metabolism. J Clin Endocrinol Metab 2010, 95:3502-3506.
17. Kauppila L.I., Polak J.F., Cupples L.A., Hannan M.T., Kiel D.P., Wilson P.W. New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis 1997, 132:245-250.
18. Pittas A.G., Harris S.S., Eliades M., Strark P., Dawson-Hughes B. Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab 2009, 94:827-832.
19. Fernandez-Real J.M., Izquierdo M., Ortega F., Gorostiaga E., Gómez-Ambrosi J., Moreno-Navarrete J.M., et al. The relationship between serum osteoclacin concentration to insulin secretion, sensitivity, and disposal with hipocaloric diet and resistance training. J Clin Endocrinol Metab 2009, 94:237-245.
20. Kanazawa I., Yamaguchi T., Yanauchi M., Yamamoto M., Kurioka S., Yano S., et al. Adiponectin is associated with changes in bone markers during glycemic control in type 2 diabetes mellitus. J Clin Endocrinol Metab 2009, 94:3031-3037.
21. Mente A., Razak F., Blankenberg S., Vuksan V., Davis A.D., Miller R., et al. Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance. Diabetes Care 2010, 33:1629-1634.